Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P17931 (
galectin-3
)
2,860
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Galectin-3
is a soluble endogenous lectin in vertebrates and is implicated in a variety of biological functions, including tumor cell adhesion, proliferation, differentiation, apoptosis, cancer progression and metastasis. In the present study, we analyzed the role of
galectin-3
in apoptosis in human malignant lymphoma.
Galectin-3
induced cell death in the HBL-2 human diffuse large B cell lymphoma cell line. A morphological examination and annexin V assays revealed that
galectin-3
-induced cell death is consistent with apoptosis and swainsonine, a potent inhibitor of
alpha-mannosidase II
, which catalyzes the synthesis of complex type N-linked oligosaccharides, inhibited
galectin-3
-induced apoptosis in HBL-2 cells. These results suggest that
galectin-3
induces apoptosis in HBL-2 cells by interacting with cell surface N-linked oligosaccharides. Furthermore, treatment of cells with Vibrio Cholerae neuraminidase enhanced
galectin-3
-induced apoptosis, suggesting that cell surface sialylation regulates
galectin-3
-induced apoptosis in human B cell lymphoma. In conclusion, our results indicate that
galectin-3
-induced apoptosis is regulated by cell surface expression of N-glycans and sialic acid in human diffuse large B cell lymphoma. This mechanism may be involved in the malignant behavior of human lymphoma cells.
...
PMID:Cell surface N-glycosylation and sialylation regulate galectin-3-induced apoptosis in human diffuse large B cell lymphoma. 1828 10